Fermenta Biotech Limited has informed the Exchange about Press Release regarding exclusive Licence Agreement with Vellore Institute of Technology ( VIT ), Vellore for Vitamin B12 Fortification Technology.
Fermenta Biotech has announced a board meeting on August 11, 2026, which approved the financial results for the quarter ended June 30, 2026. Standalone revenue was ₹111.84 Cr, profit ₹14.99 Cr. Consolidated revenue reached ₹121.82 Cr, profit ₹9.53 Cr. The company also reversed a ₹2.05 Cr inventory provision and granted...
